IDD-Xpert

Executive Summary

IDD-Xpert is a French R&D platform specializing in lifecycle management of pharmaceutical products, with a focus on oral and inhaled drug delivery. Founded in 2013 and based in Lyon, the company offers integrated services from preformulation and formulation studies to manufacturing and release of clinical and pilot batches. Leveraging Quality by Design (QbD) and Design of Experiments (DOE), IDD-Xpert provides expertise in physical characterization of powders and mixtures, process scale-up/down, and troubleshooting. Their capabilities support both new chemical entities and biotech products, bridging the gap between lab-scale development and commercial production. The company's comprehensive service portfolio includes analytical method development and formulation optimization, enabling clients to accelerate drug development timelines and reduce risks. While IDD-Xpert operates as a private entity with no disclosed financials, its niche focus on formulation and scale-up positions it as a valuable partner for pharmaceutical companies seeking to extend product lifecycles or overcome manufacturing challenges. With growing demand for efficient drug delivery solutions, particularly in inhalation, IDD-Xpert is well-placed to capture market opportunities. However, limited public information on client traction or partnerships constrains a higher conviction assessment.

Upcoming Catalysts (preview)

• TBDPartnership with a major biotech firm for oral formulation development70% success
• TBDExpansion of inhalation formulation capabilities to support clinical trials60% success
• TBDAdoption of continuous manufacturing technology for process intensification50% success